Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
63 participants
INTERVENTIONAL
2010-09-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Open-Label Trial of Pregabalin in Patients With Fibromyalgia
NCT00151528
Adolescent Fibromyalgia Study
NCT01020474
A Safety Study Of Pregabalin In Fibromyalgia
NCT00282997
A Controlled Pregabalin Trial In Fibromyalgia
NCT00230776
This Study is An Open-Label Trial Of Pregabalin In Patients With Fibromyalgia
NCT00346034
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregabalin
pregabalin
Oral capsule 75-450 mg/day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pregabalin
Oral capsule 75-450 mg/day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
12 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Childrens Hospital Los Angeles
Los Angeles, California, United States
Apex Research Institute
Santa Ana, California, United States
Florida Medical Center & Research
Miami, Florida, United States
Harmony Clinical Research, Incorporated
North Miami Beach, Florida, United States
Rheumatology Associates of Central Florida, PA
Orlando, Florida, United States
Medical Research & Health Education Foundation, Inc.
Columbus, Georgia, United States
Kosair Charities Pediatric Clinical Research Unit
Louisville, Kentucky, United States
Kosair Children's Hospital
Louisville, Kentucky, United States
University of Louisville
Louisville, Kentucky, United States
University Pediatric Rheumatology of Kentucky, LLC
Louisville, Kentucky, United States
University of Massachusetts Memorial Medical Center Department of Pediatrics
Worcester, Massachusetts, United States
Akron Children's Hospital
Akron, Ohio, United States
Akron Children's Hospital-Mahoning Valley
Boardman, Ohio, United States
Akron Children's Hospital
Boardman, Ohio, United States
University of Cincinnati Department of Psychiatry and Behavioral Neuroscience
Cincinnati, Ohio, United States
Nationwide Children's Hospital
Columbus, Ohio, United States
The Research Institute at Nationwide Children's Hospital
Columbus, Ohio, United States
Medical University of South Carolina, Pediatric Rheumatology
Charleston, South Carolina, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Carolina Research Center
Myrtle Beach, South Carolina, United States
Fatigue Consultation Clinic
Salt Lake City, Utah, United States
Bioregeneracni a rehabilitacni centrum
Říčany, , Czechia
Krishna Institute of Medical Sciences Ltd
Secunderabad, Andhra Pradesh, India
Mallikatta Neuro Center
Mangalore, Karnataka, India
Sushrut Hospital, Research Centre & Post Graduate Institute of Orthopaedics
Nagpur, Maharashtra, India
King George's Medical University
Lucknow, Uttar Pradesh, India
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Arnold LM, Schikler KN, Bateman L, Khan T, Pauer L, Bhadra-Brown P, Clair A, Chew ML, Scavone J; Pregabalin Adolescent Fibromyalgia Study Group. Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study. Pediatr Rheumatol Online J. 2016 Jul 30;14(1):46. doi: 10.1186/s12969-016-0106-4.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-020300-29
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
A0081231
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.